CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Secant Pharma

Secant Pharma is a Feasterville Trevose, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chartwell Pharmaceuticals

Chartwell Pharmaceuticals is a Congers, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osmind

Osmind is building the digital infrastructure for the next era of mental health. Osmind EHR is the #1 software for treatment-resistant mental health practices such as those in psychiatry, ketamine, psychedelic medicine, and neuromodulation.

Wake Research

Wake Researchs network of high-quality research sites and millions of patients is built on decades of experience meeting the needs of sponsors & CROs.

International Partnership for Microbicides

Developing HIV prevention products for women worldwide